Alkermes plc. Disposal Group, Including Discontinued Operation, Assets
Alkermes plc. (ALKS) had Disposal Group, Including Discontinued Operation, Assets of $0 as of 2024-12-31, per its 10-K filed 2025-02-12.
Financial Statements › Balance Sheet › Assets
us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation · last filed 2025-02-12
- 2024-12-31: Disposal Group, Including Discontinued Operation, Assets $0.00.
- 2023-12-31: Disposal Group, Including Discontinued Operation, Assets $0.00.
- 2015-03-31: Disposal Group, Including Discontinued Operation, Assets $105.20M.
| Period end | Disposal Group, Including Discontinued Operation, Assets |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-12 |
| 2023-12-31 | $0.00 10-Q · filed 2024-10-24 |
| 2015-03-31 | $105.20M 10-Q · filed 2015-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |